Connect with us

Technology

CHANDO Group Presents 20 Research Papers at IFSCC 2026 Congress in Perth

Published

on

12 years of participation underscore the Group’s growing presence in global cosmetics science

SHANGHAI and PERTH, Australia, Oct. 6, 2026 /PRNewswire/ — The 36th Congress of the International Federation of Societies of Cosmetic Chemists (IFSCC) was held in Perth, Australia, from September 28 to October 1. Building on its continued investment in skin science, ingredient science and product science, CHANDO Group participated in the global scientific gathering for the 12th consecutive year. A record 20 CHANDO Group research papers were accepted for this year’s Congress, placing the Group among the top five companies worldwide by number of accepted papers. 

The IFSCC is widely regarded as the “Nobel Prize of the cosmetics industry,” with the research it recognizes reflecting the latest advances in cosmetic science and technology worldwide. Since first participating in 2015, CHANDO Group has had 79 research papers accepted by IFSCC over 12 years, helping bring Chinese beauty innovation to the forefront of the international scientific community. This track record reflects the comprehensive innovation ecosystem developed by CHANDO Group’s R&D Center over the past 25 years. The Group’s research spans three core scientific disciplines and is supported by four technology platforms, with capabilities extending from fundamental research through product development. This integrated approach helps translate scientific advances into skincare innovations with tangible consumer benefits.

Fundamental Research Driven by Real Consumer Needs

CHANDO Group believes the value of fundamental research extends beyond scientific publications: ultimately, research must translate into products that address real consumer needs. Among the 20 research papers accepted for this year’s IFSCC Congress, technologies from several studies have already been incorporated into products across multiple CHANDO Group brands. From Himalayan extremophile-derived ingredients and precision anti-fatigue aging to barrier repair, pigmentation management, scalp care, cleansing technology, fragrance and sensory science, and women’s intimate care, the Group’s research spans a broad range of skincare and personal well-being applications.

This work is supported by three core scientific disciplines. In skin science, research ranging from longitudinal cohort studies to epigenetic approaches to skin aging is deepening CHANDO Group’s understanding of Asian skin. In ingredient science, the Group is exploring distinctive Himalayan resources to develop a portfolio of proprietary core ingredients. In product science, consumer needs guide the continued evolution of product efficacy. Each research effort starts with a real consumer need, investigates it through fundamental research, and ultimately translates the findings into products, bringing cutting-edge research into the daily lives of hundreds of millions of consumers worldwide.

From Population Insights to AI-Powered R&D: Advancing Precision “Anti-Fatigue Aging”

Skin aging is a perennial focus of skincare research, but how aging occurs—and how best to address it—varies among populations. At this year’s IFSCC Congress, CHANDO Group presented its latest research conducted in collaboration with two leading Chinese institutions.

Historically, global skin-aging research has relied predominantly on Western study populations, leaving limited systematic longitudinal evidence on the characteristics, timing and contributing factors of skin aging among Chinese consumers. To help address this gap, CHANDO Group and the Shanghai Institute of Nutrition and Health of the Chinese Academy of Sciences conducted a two-year longitudinal cohort study quantifying facial skin phenotypes in a Chinese population. The study systematically compared facial-aging phenotype data collected from more than 5,000 Chinese participants over the five-year period from 2018 to 2023 and identified changes in the aging inflection points of six major types of wrinkles. The findings showed that facial wrinkle aging among Chinese women in recent years has tended to begin earlier, progress more rapidly and enter a period of accelerated aging sooner. [1]

The study also identified trends toward shorter sleep duration and earlier initiation of smoking and alcohol consumption, suggesting an increase in fatigue-related lifestyle patterns. For the first time, the researchers quantified the differing effects of insufficient sleep, smoking and alcohol consumption on specific types of wrinkles [1], finding significant associations between multiple fatigue-related lifestyle factors and the earlier appearance of facial wrinkles. These findings not only add to scientific understanding of skin aging among Chinese consumers but also support a shift from generalized anti-aging approaches toward what CHANDO Group describes as “precision anti-fatigue aging”—targeted interventions informed by specific lifestyle factors and wrinkle types.

Building on these insights into aging among Chinese consumers, CHANDO Group has applied AI to reshape its ingredient R&D process. Conventional active-ingredient discovery often relies on experience-based screening, making it time-consuming and inefficient. In collaboration with the ACRDC R&D Center at the Yangtze Delta Region Institute of Tsinghua University, CHANDO Group established an AI-driven peptide discovery platform. Using AI-powered computational biology, the platform screened and optimized candidates from more than 2.8 million yeast proteins, ultimately identifying the new ingredient HiMurchaSin™ Super Anti-Aging Peptide. By targeting PGC-1α, a key regulator of mitochondrial energy metabolism, the ingredient promotes mitochondrial biogenesis and energy production to support precision anti-fatigue aging. It has already been incorporated into the seventh generation of CHANDO’s Super Anti-Aging Little Purple Bottle, launched in April 2026.

CHANDO Group is also expanding its research in longevity science. Its latest study identified, for the first time in the skin of Chinese women, the epigenetic regulator microRNA-1290 as a key epigenetic “switch” involved in photoaging-related telomere depletion. Following UV exposure, microRNA-1290 was significantly upregulated, weakening telomere protection and accelerating skin aging. Treatment with a Himalayan-derived HiMurchaSin filtrate + lysate significantly reversed this effect, helping protect telomeres and delay photoaging. The findings provide scientific support for the underlying anti-aging activity of HiMurchaSin™ and point toward a more targeted, epigenetic approach to addressing skin aging.

Harnessing Himalayan Resources for Sustainable Skincare Innovation

At this year’s IFSCC Congress, CHANDO Group also presented its latest advances in ingredient science. The Himalayas are both the birthplace of the CHANDO brand and a foundation of its scientific research. Drawing on the region’s distinctive extremophile resources, CHANDO has developed an integrated ingredient-development process spanning ecological resource exploration and collection, green process development and scientific efficacy validation.

From yeast extracellular vesicles and yeast-derived PDRN to Saussurea laniceps callus and rose extracellular vesicles, a growing portfolio of innovative ingredients sourced from the Himalayas is continually expanding the possibilities of skincare science.

Yeast was an early focus of this research. Using distinctive microbial resources from the Himalayas, CHANDO Group developed a sustainable yeast-derived PDRN ingredient. Conventional PDRN is typically derived from salmon sperm, while the molecular structure of CHANDO Group’s yeast-derived PDRN more closely resembles human DNA and demonstrated stronger effects in promoting cell regeneration and collagen production. The ingredient has already been used in flagship products including CHANDO’s Super Anti-Aging Little Purple Bottle Essence Cream and Peptide Essence Long-Wear Cushion Foundation. 

Plant callus culture technology also offers a sustainable way to harness rare high-altitude plants. CHANDO Group has developed Saussurea laniceps callus as the world’s first new skin-brightening ingredient derived from the Saussurea genus. Saussurea laniceps is a rare species native to high-altitude areas of the Himalayas and is classified in China as a nationally protected Class II endangered wild plant. With the required approval, CHANDO Group’s plant-ingredient R&D team used plant tissue culture technology to cultivate the material in the laboratory, overcoming the limitations of reliance on wild harvesting while enabling standardized, scalable production. Research showed skin-brightening activity at multiple levels, including cellular and protein levels [2], with multi-target inhibition of melanin production as well as antioxidant and skin-repair effects. The approach addresses limitations associated with conventional brightening ingredients that rely on a single target or high concentrations. Extracellular vesicles derived from high-altitude Rosa callus also exhibit multiple skincare activities, including barrier repair, anti-inflammatory and soothing effects, and protection against photoaging and loss of firmness. In addition, Nardostachys callus has demonstrated superior oil-control, hair-loss prevention and hair-follicle nourishment effects compared with wild-grown Nardostachys [3].

This approach enables consistent, scalable production of highly active ingredients without harvesting wild plants. As sustainability becomes an increasingly important priority for the global beauty industry, CHANDO Group is using callus culture technology to develop effective skincare ingredients while reducing reliance on wild plant resources.

In pigmentation management, CHANDO Group has focused on Asian consumers’ demand for safe, natural-looking skin brightening. A synergistic approach combining snow lotus callus with matsutake mushroom and niacinamide moves beyond conventional single-target brightening strategies, supporting gentler, more sustainable improvements in skin-tone evenness and radiance and providing a scientific basis for the development of safe and effective multi-ingredient brightening serums.

Beyond Facial Skincare: From Scalp Health to Fragrance and Sensory Science

CHANDO Group’s research now extends well beyond facial skincare into a broader range of personal-care and wellness applications.

At this year’s IFSCC Congress, the Group expanded its skin-science research into scalp care. Moving beyond conventional anti-hair-loss approaches based on broad-spectrum antimicrobial activity or a single probiotic, CHANDO Group proposed a new approach centered on maintaining microbial balance, using targeted modulation of the scalp microbiome to support anti-hair-loss efficacy. [4]

In women’s intimate care, CHANDO Group presented research from its recent expansion into women’s health. The Group investigated the use of probiotic extracellular vesicles to regulate the microbiome, exploring a gentle, safe and long-lasting approach to intimate care.

In facial and body cleansing, CHANDO Group addressed a familiar consumer concern: achieving effective cleansing without compromising the skin. The Group unveiled a new formulation technology combining a bicontinuous-phase system with selective cleansing to remove excess oils and impurities while preserving beneficial skin lipids. The concept positions cleansing not as the end of a skincare routine, but as its first step. The technology has already been applied across cleansing products from the CHANDO and Biorrier brands. 

The research presented by CHANDO Group at this year’s IFSCC Congress also extends into the growing field of fragrance and sensory science. Working with university researchers, the Group is exploring how fragrance can move beyond sensory appeal to deliver measurable functional benefits. Addressing fatigue-related concerns including poor sleep and low energy, the Group has drawn on its Himalayan research—from Nyingchi peach blossom to Himalayan fir—to scientifically evaluate the effects of fragrance ingredients and investigate their potential contribution to physical and emotional well-being. 

Advancing Chinese Beauty Innovation Through Technology

At the 2025 IFSCC Congress in Cannes, France, Chinese companies ranked second worldwide in oral presentations and first in poster presentations. That same year, China secured the right to host the 2032 IFSCC Congress, reflecting the growing international profile of Chinese cosmetics research. 

As a leading Chinese beauty company with 12 years of participation in IFSCC, CHANDO Group has both witnessed and contributed to this evolution. From its first accepted paper to its 79th, and from Himalayan extremophile resources to AI-driven precision R&D, the Group has continued to bring original Chinese cosmetics research to the international scientific community through an integrated, independently developed R&D system.

CHANDO Group’s R&D Center combines independent research with global collaboration across fundamental research, ingredient development, formulation innovation and clinical validation, with a focus on three core disciplines: skin science, ingredient science and product science.

The acceptance of 20 CHANDO Group research papers at IFSCC 2026 in Perth marks another milestone in the Group’s R&D journey. Looking ahead, the Group will continue to increase its investment in research and development and pursue original scientific breakthroughs as it contributes to the evolution of China’s beauty industry from “Made in China” to “Created in China.”

[1] Findings from research jointly conducted by CHANDO Group and the Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences
China National Radio report:
https://www.cnr.cn/shanghai/tt/20260424/t20260424_527598222.shtml?f_link_type=f_linkinlinenote&flow_extra=eyJpbmxpbmVfZGlzcGxheV9wb
3NpdGlvbiI6MCwiZG9jX3Bvc2l0aW9uIjowLCJkb2NfaWQiOiI0ZTZjMDZjNGE2YWNlZDQ3LTBkMTJjNWFhNDJmNDY5ZmUifQ%3D%3D&use_xbr
idge3=true&loader_name=forest&need_sec_link=1&sec_link_scene=im&theme=light

[2] SHU H, WANG L, TANG X, et al. Construction of a scalp microecological balance-oriented anti-hair loss system. International Federation of Societies of Cosmetic Chemists (IFSCC) Congress 2026, Perth, Australia. 2026. Poster No. 1067.

[3] LI H, REN H, QU Y, et al. Glacial water culture optimizes sustainable production of Saussurea laniceps callus: From phytochemical composition to in vitro/in vivo efficacy validation. International Federation of Societies of Cosmetic Chemists (IFSCC) Congress 2026, Perth, Australia. 2026. Poster No. 734.

[4] LI H, REN H, ZHOU Q, et al. Tissue culture-based sustainable development of Nardostachys jatamansi callus: Extract preparation and comprehensive evaluation of hair care potentials. International Federation of Societies of Cosmetic Chemists (IFSCC) Congress 2026, Perth, Australia. 2026. Poster No. 733.

 

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/chando-group-presents-20-research-papers-at-ifscc-2026-congress-in-perth-302899227.html

SOURCE CHANDO GROUP

Continue Reading

Technology

Wiremind raises €35 Million in First-Ever Funding Round

Published

on

By

The French scale-up will accelerate its international expansion and position itself as the go-to technology partner for transport operators and the live events ticketing industry

PARIS, 6 October 2026 /PRNewswire/ — Wiremind today announced it has raised €35 million from three new investors: IronWave (formerly Wendel Growth), Bpifrance Investissement (via its Large Venture fund) and Seaya Andromeda. Co-founders Colin Girault-Matz (CEO) and Charles Pierre (CTO) remain majority shareholders and retain control of the business.

Profitable since its founding in 2014, Wiremind develops revenue management, inventory and distribution software for passenger transport operators and event organisers. In 2025, its revenue grew by 67% while adding 23 new clients. Today, it serves over 80 clients across the product suite.

After 12 years of self-financed growth, Wiremind will use the new capital to fuel two strategic priorities:

International expansion: Wiremind will continue its growth in South America and increase its presence in the Middle East and APAC transport markets, building on its success across Europe and North America.Increased investment in AI: Wiremind designs its own machine learning models and optimisation algorithms, which sit at the core of its clients’ revenue, capacity, inventory and distribution systems. The funding will scale up R&D and add a new layer: large language models (LLMs), both within the decision engine that drives pricing recommendations and in tools that make the platform easier to use.

“Charles and I began our careers in the rail and aviation industries, so we have a unique understanding of the challenges our clients face. It is this first-hand knowledge that we leveraged to grow Wiremind over the years, while staying completely self-financed and investing in our own R&D. Today, we’re accelerating our efforts given the speed at which the market is adopting artificial intelligence tools. This financing round will allow us to reach rapidly growing geographic markets where decisions on technology investments are being made right now,” said Colin Girault-Matz, CEO and Co-Founder of Wiremind.

Wiremind’s flagship product, CAYZN, a revenue management platform whose ARR grew 81% in 2025, is used by more than 20 operators, including Eurostar, National Express, SNCF, Trenitalia and Transavia. PAXONE, its OSDM-native inventory and distribution system, was selected to power France’s new national Intercités ticketing system. EVENTORI, its AI-powered ticketing platform for sports clubs and event organisers, grew 140% in 2025.

Media Contact
Audrey Noel 
Press Relations
audreynoel.medias@gmail.com 

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/wiremind-raises-35-million-in-first-ever-funding-round-302898298.html

Continue Reading

Technology

Ondo Private Markets To Bring Private-Company Exposure Onchain, Starting with AI

Published

on

By

Ondo Finance launches Ondo Private Markets, providing tokenized exposure to leading private companies.The first asset, tokens referencing a leading pre-IPO AI company, is expected to begin secondary market trading this week, with robotics, cybersecurity, biotech, and infrastructure names to follow.Exposure comes through tokenized notes which provide the economic performance of a reference company’s per-share value at a qualifying liquidity event, built on Ondo’s infrastructure with $3.7B in TVL and over 1M holders.

GREENWICH, Conn., Oct. 6, 2026 /PRNewswire/ — Ondo Finance today announced Ondo Private Markets, which will bring tokenized notes delivering the economic performance of industry-defining private companies onchain. Starting with a pre-IPO AI company, the first market will launch this week with permissionless trading available 24/7 on secondary markets. Exposure to leading names across robotics, cybersecurity, biotech, infrastructure, and other sectors will follow as Ondo Private Markets builds out the broadest selection of private-company exposure onchain.

Why it matters

The vast majority of large US companies are private, with 87% exceeding $100 million in annual revenue being privately held. This includes the firms shaping the next generation of technology, meaning retail investors are sidelined for many of today’s largest wealth-creation opportunities. Exposure to leading startups remains largely concentrated among institutions and venture capitalists, and even those who get in can wait years to get out. Private markets have offered neither broad access nor an open exit.

Ondo Private Markets is built to solve both challenges by providing targeted exposure to the world’s top-performing private companies on permissionless blockchain rails where it can trade 24/7 in secondary markets. Eligible investors will be able to enter, exit, or adjust positions anytime, no longer needing to wait for an IPO to realize liquidity. 

How it works

Exposure is provided through tokenized notes, with each note’s payout linked to the per-share value realized on the referenced company’s common shares at a qualifying liquidity event. Further increasing the opportunity for investors, Ondo Private Markets tokens are both freely transferable and composable onchain, enabling them to be transferred or deployed as productive capital across the DeFi ecosystem. 

“In the US, the majority of the investment options accessible for retail are public companies, yet 87% of companies with over $100m in revenue are private. That’s where many of the leaders defining the next era of our economy are emerging, and retail investors can’t access them today. Ondo Private Markets is built to change that, bringing tokenized exposure to the world’s best companies with 24/7 trading on permissionless rails.” — Ian De Bode, Acting CEO and President, at Ondo Finance.

Ondo Private Markets builds on the same institutional-grade infrastructure behind the market-leading platforms for tokenized stocks and Treasuries, which together represent $3.7 billion in total value locked and more than 1 million cumulative holders. It extends Ondo’s mission to make traditional financial assets globally accessible onchain, opening access to an asset class that has long been out of reach for most investors.

About Ondo Finance

Ondo Finance is a blockchain-based technology company focused on tokenizing real-world assets and bringing institutional-quality financial products onchain. By bridging traditional finance and decentralized infrastructure, Ondo aims to make capital markets more accessible, transparent, and efficient.

About Ondo Private Markets

Ondo Private Markets brings private-company exposure onchain. It enables eligible investors in permitted jurisdictions to access tokenized notes designed to provide economic exposure to leading private companies. The notes are obligations of their issuer, not shares in the referenced companies, and provide no ownership or shareholder rights.

DISCLAIMERS AND LIMITATIONS: FOR NON-U.S. PERSONS ONLY. 

Important Information Regarding Token Regulatory and Eligibility Matters: The tokenized assets referenced herein (the “Tokens”) have not been registered under the US Securities Act of 1933, as amended (the “Act”) or the securities or financial instrument laws of any other jurisdiction. The Tokens may not be offered or sold in the United States or to US persons unless registered under the Act or an exemption from the registration requirements thereof is available. 

Persons who place buy orders from within the United States, or any of its states, possessions, territories or federal districts, and persons who are “U.S. persons” or acting for the account or benefit of any “U.S. persons” within the meaning of Rule 902 of Regulation S promulgated under the United States Securities Act of 1933, as amended, are prohibited from subscribing for, acquiring or redeeming the Tokens.

Important Information Regarding the Tokens: The Tokens provide their holders with economic exposure to the value of their underlying assets. However, the Tokens are not themselves stocks and the Tokens do not provide their holders with rights to hold or receive their respective underlying assets. 

The communications herein are only intended for actual or potential business relationships or technical integrations with respect to Tokens. Nothing herein constitutes any offer to sell, or any solicitation of an offer to buy, any assets. Nothing herein constitutes investment, legal, tax or financial advice. Acquiring Tokens involves risks. A holder of Tokens may incur losses, including total loss of their purchase price. Past performance may not be (and for the Tokens will not be) an indication of future results. Investors are responsible for conducting their own research, investigation, verification, checks or consultation for professional or investment advice.

This FAQ is a summary only, is qualified in its entirety by the Token Terms, the Subscription Agreement, and the Token Terms Acceptance and Redemption Claim Certification (collectively, the “Offering Documents”), and does not modify or supplement the Offering Documents. In the event of any conflict, the Token Terms control. Capitalized terms not defined in this FAQ have the meanings given in the Token Terms. Full Offering Documents, Token Terms, and Risk Factors will be provided to eligible clients before subscription and govern in the event of any inconsistency with this summary.

The communications herein may contain forward-looking statements, including, but not limited to, statements regarding future financial performance, business strategies, or expectations for the growth or development of Ondo Finance, PM Issuer Co (BVI) Limited or any of their respective affiliates (each, an “Applicable Entity”). These statements are based on management’s current expectations, estimates, projections, and beliefs, and are subject to a number of risks, uncertainties, and assumptions that could cause actual results to differ materially from those anticipated. Forward-looking statements can be identified by the use of terminology such as “may,” “will,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” or the negative of these terms or other similar expressions. Factors that could cause actual results to differ materially from those contemplated by the forward-looking statements include, but are not limited to, the following: economic, competitive, legal, governmental, and technological factors affecting the operations, markets, products, services, or prices of any Applicable Entity. No Applicable Entity undertakes any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

Additional terms and restrictions apply. See https://app.ondo.finance/legal-documentation and the Token offering documents for details.

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/ondo-private-markets-to-bring-private-company-exposure-onchain-starting-with-ai-302899388.html

SOURCE Ondo Finance

Continue Reading

Technology

GIGABYTE Showcases NVIDIA-Powered AI from Desktop to Enterprise Scale at Ai Everything Abu Dhabi 2026

Published

on

By

ABU DHABI, UAE, Oct. 6, 2026 /PRNewswire/ — GIGABYTE, the world’s leading computer brand, will showcase its latest NVIDIA-powered AI solutions at Ai Everything taking place in Abu Dhabi from October 6 to 7.

GIGABYTE introduces the AI TOP ATOM, a compact personal AI supercomputer based on the NVIDIA DGX Spark platform. Delivering 1 PFLOPS of FP4 performance, it is designed for security, local AI development, fine-tuning, and data science.  

The plug-and-play system offers 1TB to 4TB storage options and supports four-node clustering through a high-speed QSFP switch with 200GbE connectivity per node. Powered by NVIDIA ConnectX-7 networking, the four-node configuration delivers high-bandwidth inter-node communication and provides up to 512GB of aggregate unified system memory for larger and more demanding AI workloads. AI TOP ATOM enables developers and SMBs to build, test, and fine-tune AI models locally, maintaining greater control over sensitive data before scaling workloads to enterprise data centers or the cloud. 

Also on display is the GIGABYTE W775-V10, a high-performance desk-side AI workstation powered by NVIDIA GB300 Grace Blackwell Ultra Desktop Superchip, delivering up to 20 PFLOPS of FP4 performance and 748GB of coherent memory. It supports up to 400 concurrent requests, enabling secure local AI development for regulated data and proprietary models.

“AI development has traditionally required significant cloud investment or shared clusters, putting smaller teams at a disadvantage,” said Jay Lee, GM META at Giga Computing. “This gives teams the ability to develop and test locally, then scale to the data center or cloud when ready. Visit GIGABYTE at Ai Everything Abu Dhabi (Booth H3-04) to experience NVIDIA-powered scalable AI solutions.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/gigabyte-showcases-nvidia-powered-ai-from-desktop-to-enterprise-scale-at-ai-everything-abu-dhabi-2026-302898206.html

Continue Reading

Trending